Prothena Corporation plc Reports Fourth Quarter And Full Year 2013 Financial Results And Provides Research And Development Update
3/7/2014 8:43:17 AM
DUBLIN, Ireland, March 6, 2014 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion, today reported financial results for the fourth quarter and year ended December 31, 2013 and provided an update on research and development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by